New data from a global study of 120 countries has provided updated information regarding the prevalence of hepatitis B virus around the world and the effects of treatment on disease burden.
The 13-valent pneumococcal conjugate vaccine (PCV13) was first introduced in the United States in 2010. However, the effect of PCV13 on pneumococcal meningitis is not currently known.
In a recent study, researchers assessed the safety and efficacy of certain T-cell treatments for patients who develop severe viral infections following an allogenic hematopoietic stem-cell transplantation.
...
The results of a multicenter randomized clinical trial showed that health care worker-collected throat swabs are more sensitive than nasal swabs for COVID-19 rapid antigen testing, while self-collected...
